Vialwirebiotech, curated
October 1, 2026, 10:36 AM
July 29, 2026
- 10:34 AM · Pharmaceutical Technology10:34 AMDimerix acquisition of DMX-652 bolsters kidney disease development — Pharmaceutical Technology
- 10:17 AM · Pharmaceutical Executive10:17 AM<![CDATA[FDA Approves Viatris’ Gwyn Lo Contraceptive Patch ]]> — Pharmaceutical Executive
- 9:00 AM · BioWorld9:00 AMTorrey Pines Medicine secures funding to advance metabolic programs — BioWorld
- 9:00 AM · BioWorld9:00 AMCore Biomedicine licenses Eisai oncology programs, raises funds — BioWorld
- 9:00 AM · BioWorld9:00 AMMJFF grant supports Shape’s SHP-201 through IND-enabling studies — BioWorld
- 8:00 AM · Drug Discovery World8:00 AMPhase I study for prevention of chemotherapy-induced peripheral neuropathy — Drug Discovery World
- 6:30 AM · Drug Discovery World6:30 AMAsthma drug Trixeo recommended for approval in the EU — Drug Discovery World
- 5:21 AM · Drug Discovery World5:21 AMGSK plans new flagship R&D centre and £400m investment in UK — Drug Discovery World
- 3:50 AM · Pharmaceutical Technology3:50 AMEisai and CORE Biomedicine agree on global licence for oncology pipeline — Pharmaceutical Technology
July 28, 2026
- 5:21 PM · SCMP — Tech5:21 PMNvidia CEO Jensen Huang meets US officials as scrutiny grows over China chip access — SCMP — Tech
- 12:00 PM · BioWorld12:00 PMAltimmune on PEth to phase III in AUD with pemvi — BioWorld
- 12:00 PM · BioWorld12:00 PMKolon Tissuegene shares fall as TG-C misses knee OA endpoints — BioWorld
- 12:00 PM · BioWorld12:00 PMAmgen makes its case for hearing to keep Tavneos on the US market — BioWorld
- 12:00 PM · BioWorld12:00 PMEpitel raises $26M for wireless EEG system for seizure monitoring — BioWorld
- 11:00 AM · SCMP — Tech11:00 AMRecord Chinese biotech out-licensing meets rising US scrutiny — SCMP — Tech
- 9:19 AM · TechCrunch9:19 AMRecursive Superintelligence signs $410 compute deal with Amazon — TechCrunch
- 9:00 AM · BioWorld
- 9:00 AM · BioWorld9:00 AMSuven Life Sciences divulges new muscarinic M4 receptor PAMs — BioWorld
- 9:00 AM · BioWorld9:00 AMShanghai Escugen Biotechnology reports new TROP2-targeting ADCs — BioWorld
- 9:00 AM · BioWorld9:00 AMBiomarin and n-Lorem partner on ASO for ReNU syndrome — BioWorld
- 9:00 AM · BioWorld9:00 AMShanghai Jeyou Pharmaceutical identifies new DHX9 inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMPromatix advances PBS-293-exatecan with Innovate UK grant — BioWorld
- 9:00 AM · BioWorld
- 9:00 AM · BioWorld9:00 AMDecoy’s D-MAV shows in vitro activity against Zaire Ebola virus — BioWorld
- 9:00 AM · BioWorld9:00 AMAscletis Pharma’s ASC-37 shows weight loss in DIO mice — BioWorld
- 9:00 AM · BioWorld9:00 AMDYNE-302 gets IND for facioscapulohumeral muscular dystrophy — BioWorld
- 8:00 AM · BioPharma Dive8:00 AMAn eye drug biotech banks $118M and stocks its executive suite — BioPharma Dive
- 7:29 AM · SCMP — Tech7:29 AMHong Kong drives trials for breast cancer, eye treatments across Greater Bay Area — SCMP — Tech
- 7:27 AM · FT — Pharmaceuticals7:27 AMGSK to shut historic Stevenage hub as it announces £1.9bn cost-saving drive — FT — Pharmaceuticals
- 6:00 AM · STAT News
- 5:54 AM · SCMP — Tech5:54 AMTop Los Angeles diabetes doctor Shen Yang joins China’s Westlake University — SCMP — Tech
- 5:00 AM · Drug Discovery World5:00 AMPhase III trials confirm benefits of Lilly’s triple agonist retatrutide — Drug Discovery World
- 1:10 AM · Science (News)1:10 AMActivists and leaders at global HIV meeting decry price of prevention drug — Science (News)
July 27, 2026
- 12:00 PM · BioWorld12:00 PMTidalsense raises $19M for AI-powered COPD diagnostic platform — BioWorld
- 12:00 PM · BioWorld12:00 PMMaplight aims to differentiate muscarinic agonist from competitors — BioWorld